Dr
Johns Hopkins
Author in the following contributions
- Dosimetric Impact of Ac-227 in Accelerator-Produced Ac-225
- Impact of Target Cell Number on Target cell and Tissue Dose for Antibody-Mediated delivery of Alpha-Emitters
- Evaluation of 225Ac-anti-VLA-4 for targeted α-therapy for treatment of metastatic melanoma
- Application of a trabecular and cellular model of bone marrow dosimetry for targeted 223Ra therapy
- Small Scale Modeling and Dosimetry for the Salivary Gland: Application to 177Lu- and 225Ac-PSMA Therapy
- Pharmacokinetic variability of in vivo generated 213Bi and vector labeled 225Ac in murine cancer models